3rd Quarter - Report
THE SMITH-FREE GROUP, LLC for GVB BIOPHARMA
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Agriculture AGR
H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Discussions relating to regulation of the CBD industry. Monitored discussions relating to regulation of Delta-8 THC. Monitored regulations on hemp/CBD issues. Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK S DEUSER | — |
| MICHAEL A. GAFFIN New | Leg. Director, Sen. Sherrod Brown; Leg. Director, Rep. Rob Andrews; Leg. Asst., Rep. Anna Eshoo; Jr. Leg. Assoc., House Ed. and Labor Committee, Rep. George Miller; Staff Asst., Senate HELP Committee, Sen. Edward Kennedy |
| TREVOR W. KOLEGO | — |
| IAN S.D. MAIR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.